Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;78(2):205-13.

Factors influencing sustainable efficacy of smoking cessation treatment with varenicline beyond nine months

Satoko Shimadu  1 , Nobuyuki Hamajima  2 , Yu Okada  1 , Tomoyo Oguri  3 , Toyoaki Murohara  4 , Nobutaro Ban  5 , Mitsuo Sato  1 , Yoshinori Hasegawa  1
Affiliations

Factors influencing sustainable efficacy of smoking cessation treatment with varenicline beyond nine months

Satoko Shimadu et al. Nagoya J Med Sci. 2016 May.

Abstract

Pharmacological therapies play an important role in the success of interventions for smoking cessation; however, long-term follow-up studies with analysis of influencing factors are scarce. We examined the sustainable effects of smoking cessation therapy with varenicline, beyond nine months as well as the factors influencing effectiveness. Our sample consisted of 193 patients (126 men [68.2%], 67 women [31.8%], aged 26 to 85 years) who underwent varenicline therapy at the Nagoya University Hospital between January 2009 and October 2013. We examined their clinical records and also conducted a mail survey and evaluated success rates of smoking cessation therapy beyond nine months. Overall, 95.8% (185/193) of the patients had at least one complication. The response rate of questionnaires at the end of smoking cessation was 61.6% (119/193). The smoking cessation rate continued to decline for one year and leveled off afterwards. Smoking cessation rates tended to correlate with an increasing number of outpatient visits. Logistic regression analysis showed that two factors, young age and high Beck Depression Inventory-II (BDI-II) scores, were inversely correlated with success rates of smoking cessation. From the results of this study, aggressive intervention would needed for younger patients or patients with higher BDI-II scores.

Keywords: BDI-II score; smoking cessation rate; smoking cessation therapy; varenicline.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of the selection of study participants
See this image and copyright information in PMC

References

    1. World health organization. Tobacco free initiative: Building Blocks for Tobacco Control: A Handbook, 2004.
    1. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet, 2007; 370: 2044–2053. - PubMed
    1. The Japanese Circulation Society Study Group. Smoking cessation guideline. Circ J, 2005; 69: 1006–1103.
    1. Nakamura M, Oshima A, Fujimoto Y, Maruyama N, Ishibashi T, Reeves KR. Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther, 2007; 29: 1140–1156. - PubMed
    1. Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther, 2009; 31: 463–491. - PubMed

LinkOut - more resources